缺少TAAR1功能会增加甲基胺诱导的背脊拉菲血清蛋白神经元的兴奋性,并驱动大量的甲基胺摄入量
Samantha M Rios1, John R K Mootz1, Tamara J Phillips1,2
1Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
概括
遗传因素影响甲基胺 (MA) 的摄入. 非功能性微量氨基关联受体1 (TAAR1) 通过通过血清素载体改变血清素神经元活动来增加MA奖励灵敏度和摄入量.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基胺 (MA) 是一种精神兴奋剂,其摄入量因奖励和厌恶效应而变化.
- 影响MA敏感性的遗传因素对于开发有效治疗方法至关重要.
- 背脊拉菲赛洛托尼神经元活动与奖励处理有关.
研究的目的:
- 研究微氨基关联受体1 (TAAR1) 在MA奖励敏感性和摄入中的作用.
- 为了检查TAAR1功能对背脊拉菲血清激素神经元活动对MA的反应的影响.
- 为了阐明TAAR1和血清素载体在MA神经化学效应中的相互作用.
主要方法:
- 整个细胞补丁电生理学被用于从高 (MAHDR) 或低 (MALDR) MA摄入量小鼠的背脊拉菲血清激素神经元.
- MAHDR小鼠具有非功能性TAAR1 (Taar1m1J) 的突变,而MALDR小鼠具有功能性TAAR1 (Taar1+).
- 实验涉及单独使用MA和与血清素自身受体对抗剂或血清素输送剂对抗剂 (fluoxetine) 联合使用MA.
主要成果:
- 在MALDR小鼠中,MA降低了背脊拉菲类血清激素神经元活动,但不是MAHDR小鼠.
- 在对抗剂的存在下,MA在MAHDR小鼠中增强了血清神经元活性,这种效应在具有功能TAAR1.1的敲入小鼠中被废除了.
- 素阻断了非功能TAAR1的小鼠中的MA诱导的强化,这表明胺转运器参与.
结论:
- TAAR1的功能极大地调节了MA奖励的敏感性和摄入量.
- 非功能性TAAR1导致MA的消耗增加,因为它改变了MA对背部神经元的作用.
- TAAR1与血清素载体相互作用,调节MA诱导的神经元活动的变化.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
430
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
430
Stimulants
157
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
157
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
928
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
928
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


